Acorda Therapeutics, Inc. EBITDA Margin 2010-2024 | ACORQ
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Acorda Therapeutics, Inc. (ACORQ) over the last 10 years. The current EBITDA margin for Acorda Therapeutics, Inc. as of March 31, 2024 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2024-03-31 |
$0.12B |
$0.02B |
19.83% |
2023-12-31 |
$0.12B |
$0.04B |
31.36% |
2023-09-30 |
$0.11B |
$0.03B |
29.73% |
2023-06-30 |
$0.12B |
$0.03B |
25.64% |
2023-03-31 |
$0.12B |
$0.02B |
16.95% |
2022-12-31 |
$0.12B |
$0.02B |
12.61% |
2022-09-30 |
$0.13B |
$0.00B |
2.40% |
2022-06-30 |
$0.12B |
$-0.02B |
-12.30% |
2022-03-31 |
$0.12B |
$-0.02B |
-13.82% |
2021-12-31 |
$0.13B |
$-0.03B |
-22.48% |
2021-09-30 |
$0.13B |
$-0.09B |
-71.54% |
2021-06-30 |
$0.15B |
$-0.05B |
-34.21% |
2021-03-31 |
$0.15B |
$-0.04B |
-28.57% |
2020-12-31 |
$0.15B |
$-0.02B |
-13.07% |
2020-09-30 |
$0.17B |
$0.35B |
210.91% |
2020-06-30 |
$0.16B |
$0.07B |
45.00% |
2020-03-31 |
$0.18B |
$0.06B |
32.39% |
2019-12-31 |
$0.19B |
$0.02B |
7.81% |
2019-09-30 |
$0.21B |
$-0.33B |
-158.29% |
2019-06-30 |
$0.31B |
$-0.05B |
-17.65% |
2019-03-31 |
$0.41B |
$0.02B |
5.38% |
2018-12-31 |
$0.47B |
$0.06B |
13.59% |
2018-09-30 |
$0.59B |
$0.20B |
33.22% |
2018-06-30 |
$0.59B |
$0.17B |
28.57% |
2018-03-31 |
$0.57B |
$0.12B |
20.03% |
2017-12-31 |
$0.59B |
$0.10B |
17.04% |
2017-09-30 |
$0.54B |
$0.02B |
3.89% |
2017-06-30 |
$0.54B |
$0.02B |
3.36% |
2017-03-31 |
$0.52B |
$-0.00B |
-0.19% |
2016-12-31 |
$0.52B |
$-0.01B |
-0.96% |
2016-09-30 |
$0.51B |
$-0.00B |
-0.59% |
2016-06-30 |
$0.52B |
$0.03B |
4.98% |
2016-03-31 |
$0.51B |
$0.04B |
8.64% |
2015-12-31 |
$0.49B |
$0.06B |
12.17% |
2015-09-30 |
$0.48B |
$0.06B |
11.67% |
2015-06-30 |
$0.44B |
$0.05B |
11.42% |
2015-03-31 |
$0.42B |
$0.05B |
12.35% |
2014-12-31 |
$0.40B |
$0.05B |
13.18% |
2014-09-30 |
$0.38B |
$0.06B |
16.45% |
2014-06-30 |
$0.36B |
$0.05B |
14.04% |
2014-03-31 |
$0.35B |
$0.05B |
13.58% |
2013-12-31 |
$0.34B |
$0.04B |
12.17% |
2013-09-30 |
$0.33B |
$0.03B |
8.92% |
2013-06-30 |
$0.32B |
$0.03B |
8.52% |
2013-03-31 |
$0.31B |
$0.02B |
7.52% |
2012-12-31 |
$0.31B |
$0.03B |
11.15% |
2012-09-30 |
$0.30B |
$0.03B |
11.11% |
2012-06-30 |
$0.31B |
$0.06B |
18.21% |
2012-03-31 |
$0.30B |
$0.05B |
17.88% |
2011-12-31 |
$0.29B |
$0.05B |
15.75% |
2011-09-30 |
$0.29B |
$0.05B |
17.48% |
2011-06-30 |
$0.26B |
$0.03B |
11.28% |
2011-03-31 |
$0.24B |
$0.02B |
8.94% |
2010-12-31 |
$0.19B |
$0.00B |
0.00% |
2010-09-30 |
$0.14B |
$-0.03B |
-19.42% |
2010-06-30 |
$0.09B |
$-0.06B |
-65.56% |
2010-03-31 |
$0.06B |
$-0.08B |
-125.00% |
2009-12-31 |
$0.05B |
$-0.07B |
-137.04% |